Recent

% | $
Quotes you view appear here for quick access.

Celgene Corporation Message Board

  • bearofbleecker bearofbleecker Jul 11, 2013 12:09 PM Flag

    Phase III Revlimid trial in Europe

    While I'm grateful for the increase in share price, it strikes me that testing Revlimid/dexamethasonce vs thalidomide/melphalon/dex is a bit like testing the new Mustang against the 1983 Ford Fairlane. I don't think anyone was truly surprised by this outcome, but then the mills of European medicine grind slowly. The firstline thereapy for newly diagnosed MM in the US is probably already Revlimid/Kyprolis/dex.

 
CELG
105.58+1.88(+1.81%)1:08 PMEDT